Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
29.4M
-
Shares change
-
-1.03M
-
Total reported value, excl. options
-
$1.1B
-
Value change
-
-$40.4M
-
Put/Call ratio
-
0.12
-
Number of buys
-
68
-
Number of sells
-
-41
-
Price
-
$37.55
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q3 2018
132 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q3 2018.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.4M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3.34M shares), BlackRock Inc. (2.17M shares), Vivo Capital, LLC (2.05M shares), ALLIANCEBERNSTEIN L.P. (1.58M shares), JPMORGAN CHASE & CO (1.53M shares), VHCP Management II, LLC (1.42M shares), STATE STREET CORP (1.32M shares), WELLINGTON MANAGEMENT GROUP LLP (1.2M shares), PERCEPTIVE ADVISORS LLC (991K shares), and CITADEL ADVISORS LLC (981K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.